|
|||||
|
|

Technology and consulting giant IBM (NYSE:IBM) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 12.1% year on year to $19.69 billion. Its non-GAAP profit of $4.52 per share was 5.4% above analysts’ consensus estimates.
Is now the time to buy IBM? Find out in our full research report (it’s free for active Edge members).
IBM’s Q4 performance was marked by growth in software and infrastructure, which drove the company to surpass Wall Street’s revenue and profit expectations. Management credited the momentum to strong demand for AI- and automation-centric solutions, as well as continued adoption of its Z17 mainframe platform. CEO Arvind Krishna noted that “software grew 9%, our highest annual growth rate in history,” highlighting the impact of IBM’s focus on hybrid cloud and AI. Consulting services also contributed modestly, with clients increasingly seeking help to integrate AI at scale.
Looking ahead, IBM’s management expects momentum in software, generative AI, and strategic acquisitions to continue shaping the company’s trajectory. Krishna emphasized that the “opportunity is to make it easy for clients to build AI that is specific to their data, their processes, and their competitive needs,” pointing to the integration of new platforms like Confluent and ongoing innovation as key catalysts. CFO Jim Kavanaugh added that the company’s durable free cash flow generation would support ongoing investment in innovation and margin expansion, while acknowledging potential headwinds related to acquisition dilution and product cycle dynamics.
IBM’s Q4 performance was shaped by surging demand for AI-driven solutions, mainframe momentum, and successful integration of key acquisitions, offset by a slight decline in operating margin.
IBM’s outlook is underpinned by ongoing demand for AI and hybrid cloud, continued software growth, and integration of acquisitions, while facing margin headwinds from product cycles and M&A dilution.
Going forward, the StockStory team will closely watch (1) the pace of integration and synergy realization from the Confluent acquisition, (2) ongoing adoption rates and monetization of IBM’s AI and automation platforms, and (3) the conversion of consulting backlog into revenue, especially for AI-related projects. Execution on margin expansion and effective management of acquisition-related dilution will also be important markers of progress.
IBM currently trades at $316.72, up from $294.21 just before the earnings. Is there an opportunity in the stock?See for yourself in our full research report (it’s free).
If your portfolio success hinges on just 4 stocks, your wealth is built on fragile ground. You have a small window to secure high-quality assets before the market widens and these prices disappear.
Don’t wait for the next volatility shock. Check out our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).
Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.
| Feb-17 | |
| Feb-17 | |
| Feb-17 | |
| Feb-17 |
Stock Market Today: Dow, Tech Futures Slide; Nvidia, Palantir, Tesla Extend Losses (Live Coverage)
IBM
Investor's Business Daily
|
| Feb-16 | |
| Feb-16 | |
| Feb-14 |
Phonographs, Player Pianos and Betamax: The Inventions That Transformed Entertainment
IBM
The Wall Street Journal
|
| Feb-14 | |
| Feb-13 | |
| Feb-13 | |
| Feb-13 | |
| Feb-13 | |
| Feb-12 | |
| Feb-12 | |
| Feb-12 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite